104 related articles for article (PubMed ID: 10638971)
1. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
5. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of APO-1/Fas and interleukin-1beta-converting enzyme in osteosarcoma correlate with response to chemotherapy.
Holzer G; Trieb K; Koschat M; Blahovec H; Kotz R
Anticancer Res; 2002; 22(3):1869-72. PubMed ID: 12168884
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients.
Conroy SE; Sasieni PD; Fentiman I; Latchman DS
Eur J Cancer; 1998 May; 34(6):942-3. PubMed ID: 9797714
[No Abstract] [Full Text] [Related]
8. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90.
Ripley BJ; Isenberg DA; Latchman DS
J Autoimmun; 2001 Dec; 17(4):341-6. PubMed ID: 11771959
[TBL] [Abstract][Full Text] [Related]
10. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
12. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of the treatment of reserving limb for patients with malignant bone tumor].
Liao QD; Chen Q; Zhong D; Li KH; Hu JZ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):723-7. PubMed ID: 17062939
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
15. Hematogenous micrometastases in osteosarcoma patients.
Bruland OS; Høifødt H; Saeter G; Smeland S; Fodstad O
Clin Cancer Res; 2005 Jul; 11(13):4666-73. PubMed ID: 16000559
[TBL] [Abstract][Full Text] [Related]
16. Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group.
Kager L; Zoubek A; Kastner U; Kempf-Bielack B; Potratz J; Kotz R; Exner GU; Franzius C; Lang S; Maas R; Jürgens H; Gadner H; Bielack S;
J Clin Oncol; 2006 Apr; 24(10):1535-41. PubMed ID: 16575004
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 antibodies in autism.
Evers M; Cunningham-Rundles C; Hollander E
Mol Psychiatry; 2002; 7 Suppl 2():S26-8. PubMed ID: 12142940
[No Abstract] [Full Text] [Related]
18. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
19. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
[TBL] [Abstract][Full Text] [Related]
20. [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients].
Nathrath M; Kremer M; Letzel H; Remberger K; Höfler H; Ulle T
Klin Padiatr; 2002; 214(4):230-5. PubMed ID: 12165907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
